- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04638998
Assessing Neuroinflammation in GWI Using MRS
Assessing Neuroinflammation in Gulf War Illness With Whole-Brain Magnetic Resonance Spectroscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This proposal is for a Tier 1 (Discovery) study that uses a human, cross-sectional, observational neuroimaging approach to measure neuroinflammation in Gulf War Illness (GWI). A whole-brain magnetic resonance spectroscopic imaging (MRSI) scan will be used to detect multiple markers of neuroinflammation in 30 individuals with GWI and 30 healthy veteran controls. The investigators have fully tested the MRSI scan in several patient groups, and have found strong evidence of neuroinflammation in fibromyalgia and chronic fatigue syndrome - conditions the investigators believe involve abnormal central immune system processing. The investigators have not, however, performed the scan on individuals with GWI. The discovery study will allow investigators to transfer this existing technology to the GWI field. This project meets the core Special Interest of investigating dysregulation between the immune and neurological systems in the brain.
The investigators' central hypothesis is that GWI involves chronic neuroinflammation. The symptoms of GWI (e.g. fatigue, musculoskeletal pain, sleep disturbances, and cognitive dysfunction) overlap heavily with classic cytokine-induced sickness responses. In the case of GWI, microglial cells in the brain can be pushed into a hypersensitized state by toxins or abnormal immune challenges, leading to chronic overproduction of pro-inflammatory factors that result in the primary symptoms of GWI.
To test the central hypothesis, it is necessary to measure neuroinflammation in humans in vivo. However, most techniques are too invasive for use in living individuals. To address that problem, the investigators use an MRSI scan which provides metabolite concentrations in 4,000 separate voxels, giving whole-brain coverage. The scan yields measurements for: Myo-inositol (a marker of glial cell proliferation), lactate (a product of anaerobic metabolism), choline (a sign of cellular breakdown), and N-acetylaspartate (a marker of neuronal health). The scan also provides absolute brain temperature, which is shown to be elevated with severe neuroinflammation. The five main outcomes are as follows:
Myo-inositol (MI): Higher values represent greater microglia proliferation or gliosis.
Lactate (Lac): Higher values represent more severe inflammatory activity.
Choline (Cho): Higher values indicate greater cell turnover (inflammation, gliosis, or demyelination).
NAA: Lower values represent neurodegeneration.
Temperature: Higher values represent greater neuroinflammation. Metabolite and water-reference data will be analyzed using the MIDAS package and thermometry extension41. Absolute brain temperatures (in °C) within each voxel will be calculated by measuring the distance of the temperature-invariant NAA peak from the temperature-variant water peak using the formula: Tbrain = -102.76 × Δwater-NAA + 310.5°C, which has been validated in our scanner to produce reliable readings. Temperature will be expressed on absolute values in °C.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Between the ages of 46 and 70
- Veterans who meet the Kansas inclusion criteria .The Kansas Inclusion Criteria are a set of the most frequently reported symptoms experienced by Gulf War veterans. This frequency and severity of the symptoms reported by the participant indicate whether the person has Gulf War Illness or not. The Kansas Inclusion Criteria is the gold standard for identifying veterans with GWI in the field. The criteria are attached.
- Present in Persian Gulf between 1990 and August 1991
- Forward deployed (in Iraq or Kuwait)
Exclusion Criteria:
- Usage of experimental medications, opioid analgesics, psychostimulants (except caffeine), or benzodiazepines
- Uncontrolled diabetes, autoimmune disorders, and thyroid disorders.
- Major cardiovascular illness, cancer, or have any contraindications for MRI (including metallic implants or claustrophobia)
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy Control
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991.
This cohort do not experience any Gulf War Illness symptoms.
|
MRSI is a non invasive imaging technique used to detect neuroinflammation.
Other Names:
Blood will be drawn to assess systemic inflammation in Gulf War verterans.
|
Gulf War Illness
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991.
The men in this cohort will also meet the Kansas Inclusion Criteria for GWI.
|
MRSI is a non invasive imaging technique used to detect neuroinflammation.
Other Names:
Blood will be drawn to assess systemic inflammation in Gulf War verterans.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concentration of myoinositol in the brain
Time Frame: 20 minutes
|
The concentration of myoinositol will be measured in the brain using MRI as a measure of neuroinflammation.
This will be measured in both the control and experimental groups.
|
20 minutes
|
Concentration of lactate in the brain
Time Frame: 20 minutes
|
The concentration of lactate will be measured in the brain using MRI as a measure of neuroinflammation.
The concentration will be expressed in water-normed "Institutional Units".
This will be measured in both the control and experimental groups.
|
20 minutes
|
Concentration of choline in the brain
Time Frame: 20 minutes
|
The concentration of choline will be measured in the brain using MRI as a measure of neuroinflammation.
This will be measured in both the control and experimental groups.
|
20 minutes
|
Concentration of N-acetylaspartate in the brain
Time Frame: 20 minutes
|
The concentration of N-acetylaspartate will be measured in the brain using MRI as a measure of neuroinflammation.
This will be measured in both the control and experimental groups.
|
20 minutes
|
Temperature in the brain
Time Frame: 20 minutes
|
The temperature of the brain will be measured using MRI as a measure of neuroinflammation.
This will be measured in both the control and experimental groups.
|
20 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jarred Younger, PhD, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-3000004528
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gulf War Syndrome
-
American UniversityBoston University; Massachusetts General Hospital; Georgetown University; Nova...RecruitingGulf War Syndrome | Gulf War IllnessUnited States
-
Roskamp Institute Inc.Boston University; United States Department of Defense; Palo Alto Veterans Institute...Recruiting
-
University of UtahVA Salt Lake City Health Care SystemWithdrawn
-
Baylor College of MedicineTexas A&M University; Michael E. DeBakey VA Medical CenterNot yet recruiting
-
Nova Southeastern UniversityBoston University; Weill Medical College of Cornell University; RTI InternationalRecruiting
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompletedGulf War Illness | Persian Gulf War SyndromeUnited States
-
South Florida Veterans Affairs Foundation for Research...Unknown
-
VA Office of Research and DevelopmentCompleted
-
University of Alabama at BirminghamCongressionally Directed Medical Research ProgramsRecruiting
-
Baylor College of MedicineMichael E. DeBakey VA Medical CenterTerminated
Clinical Trials on Magnetic Resonance Spectroscopic Imaging
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)Completed
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMalignant Brain GliomaUnited States
-
Susan ChangGE Healthcare; Sigma-Aldrich; Phillips-MedisizeRecruitingRecurrent WHO Grade III Glioma | WHO Grade III Glioma | WHO Grade II Glioma | Recurrent World Health Organization (WHO) Grade II GliomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Daniel M. SpielmanNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Central Nervous System Neoplasm | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnBrain and Central Nervous System Tumors
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated
-
University of CincinnatiActive, not recruitingProstate CancerUnited States